Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 16, 2014 13:04 ET | Source: Genetic Technologies

Genetic Technologies Announces Completion of Share Transaction With Dr. Mervyn Jacobson

MELBOURNE, AUSTRALIA--(Marketwired - May 16, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announced today the completion of a series of transactions with the Company's largest...
April 30, 2014 14:55 ET | Source: Genetic Technologies

Genetic Technologies Files Activities Report for the Quarter Ended March 31, 2014

MELBOURNE, AUSTRALIA--(Marketwired - Apr 30, 2014) - Genetic Technologies Limited (NASDAQ: GENE) (ASX: GTG) today announced it has filed its Quarterly Activities Report for the Quarter ended March...
April 17, 2014 02:49 ET | Source: Genetic Technologies

Results From Extraordinary General Meeting

MELBOURNE, AUSTRALIA--(Marketwired - Apr 17, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) advises that an Extraordinary General Meeting of shareholders was held at 10.00 am today...
April 07, 2014 20:07 ET | Source: Alchemia

Alchemia Announces Presentation of Data on Its Discovery of a Potential New Cancer Stem Cell Therapeutic Target During the 2014 AACR Annual Meeting

BRISBANE, AUSTRALIA--(Marketwired - Apr 7, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that it will be presenting proprietary data at the American...
March 24, 2014 12:46 ET | Source: Genetic Technologies

Genetic Technologies Executes Agreement With Promega Corporation

MELBOURNE, AUSTRALIA--(Marketwired - Mar 24, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announced today that in compliance with the ASX Continuous Disclosure Rules, the company...
March 07, 2014 05:15 ET | Source: Genetic Technologies

Genetic Technologies Announces Publication of Economic Modeling Study Supporting Cost-Effectiveness of BREVAGen(TM) to Direct Tamoxifen Chemoprevention

MELBOURNE, AUSTRALIA--(Marketwired - Mar 7, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) today announced the recent online publication in the journal Applied Health Economics and...
March 03, 2014 13:43 ET | Source: Alchemia

Alchemia to Present at the 26th Annual ROTH Conference on March 12, 2014

BRISBANE, AUSTRALIA--(Marketwired - Mar 3, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that Thomas Liquard, the Company's Chief Executive Officer,...
February 27, 2014 06:00 ET | Source: Alchemia

Alchemia to Present at the Cowen and Company 34th Annual Health Care Conference on March 3, 2014

BRISBANE, AUSTRALIA--(Marketwired - Feb 27, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that Thomas Liquard, the Company's Chief Executive Officer...
February 24, 2014 11:20 ET | Source: Genetic Technologies

Genetic Technologies Provides Further Update on Corporate Structure

MELBOURNE, AUSTRALIA--(Marketwired - Feb 24, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to advise that Ms. Alison Mew has confirmed that she will return to full-time...
February 24, 2014 06:00 ET | Source: Alchemia

Alchemia Appoints Thomas Liquard as Chief Executive Officer

BRISBANE, AUSTRALIA--(Marketwired - Feb 24, 2014) - Alchemia Limited, (ASX: ACL) a drug discovery and development company, today announced the appointment of Thomas Liquard as Chief Executive...